# Nurix Therapeutics, Inc.: Form 8-K, filed Aug 22, 2025

- Company: [Nurix Therapeutics, Inc.](/companies/nrix.md) (CIK 1549595)
- Form: 8-K
- Filed: 2025-08-22
- Accepted by EDGAR: Aug 22, 2025, 16:01 ET
- Period: 2025-08-19
- Accession: 0001549595-25-000105
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1549595/000154959525000105/nrix-20250819.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1549595/000154959525000105/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1549595/000154959525000105/nrix-20250819.htm

Filed Aug 22, 2025.
Source: SEC EDGAR, the filing index for accession 0001549595-25-000105. Last ingested by Listed: Nov 5, 2026, 13:59 ET. No prices; not investment advice.